EMERGENT BIOSOLUT (Germany) Top Management
ER4 Stock | EUR 6.78 0.52 7.12% |
EMERGENT BIOSOLUT employs about 18 people. The company is managed by 16 executives with a total tenure of roughly 162 years, averaging almost 10.0 years of service per executive, having 1.13 employees per reported executive. Evaluation of EMERGENT BIOSOLUT's management performance can provide insight into the firm performance.
Fuad ElHibri Chairman Executive Chairman of the Board |
Robert Kramer President CFO, Interim Executive Vice President - Corporate Services Division, Principal Financial and Accounting Officer, Treasurer |
EMERGENT |
EMERGENT BIOSOLUT Management Team Effectiveness
EMERGENT BIOSOLUT's management efficiency ratios could be used to measure how well EMERGENT BIOSOLUT manages its routine affairs as well as how well it operates its assets and liabilities.EMERGENT BIOSOLUT Workforce Comparison
EMERGENT BIOSOLUT is rated # 2 in number of employees category among its peers. The total workforce of Other industry is currently estimated at about 21,557. EMERGENT BIOSOLUT adds roughly 18.0 in number of employees claiming only tiny portion of all equities under Other industry.
EMERGENT BIOSOLUT Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. EMERGENT BIOSOLUT Price Series Summation is a cross summation of EMERGENT BIOSOLUT price series and its benchmark/peer.
EMERGENT BIOSOLUT Notable Stakeholders
An EMERGENT BIOSOLUT stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as EMERGENT BIOSOLUT often face trade-offs trying to please all of them. EMERGENT BIOSOLUT's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting EMERGENT BIOSOLUT's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Fuad ElHibri | Executive Chairman of the Board | Profile | |
Robert Kramer | CFO, Interim Executive Vice President - Corporate Services Division, Principal Financial and Accounting Officer, Treasurer | Profile | |
Katherine Strei | Executive Vice President, Human Resources and Communications, Chief Human Resources Officer | Profile | |
Atul Saran | Executive Vice President Corporate Development, General Counsel and Corporate Secretary | Profile | |
Adam Havey | Executive Vice President and Presidentident - BioDefense Division | Profile | |
Richard Lindahl | Chief Financial Officer, Executive Vice President, Treasurer | Profile | |
Sue Bailey | Independent Director | Profile | |
Jerome Hauer | Independent Director | Profile | |
Kathryn Zoon | Independent Director | Profile | |
Seamus Mulligan | Director | Profile | |
George Joulwan | Independent Director | Profile | |
Louis Sullivan | Independent Director | Profile | |
Ronald Richard | Lead Independent Director | Profile | |
Zsolt Harsanyi | Independent Director | Profile | |
Sean Kirk | Executive Vice President Manufacturing and Technical Operations | Profile | |
Marvin White | Director | Profile |
About EMERGENT BIOSOLUT Management Performance
The success or failure of an entity such as EMERGENT BIOSOLUT often depends on how effective the management is. EMERGENT BIOSOLUT management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of EMERGENT management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the EMERGENT management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of EMERGENT BIOSOLUT's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, EMERGENT BIOSOLUT's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of EMERGENT BIOSOLUT's management manipulating its earnings.
EMERGENT BIOSOLUT Workforce Analysis
Traditionally, organizations such as EMERGENT BIOSOLUT use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare EMERGENT BIOSOLUT within its industry.EMERGENT BIOSOLUT Manpower Efficiency
Return on EMERGENT BIOSOLUT Manpower
Revenue Per Employee | 62.3M | |
Revenue Per Executive | 70.1M | |
Net Loss Per Employee | 12.4M | |
Net Loss Per Executive | 14M |
Complementary Tools for EMERGENT Stock analysis
When running EMERGENT BIOSOLUT's price analysis, check to measure EMERGENT BIOSOLUT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMERGENT BIOSOLUT is operating at the current time. Most of EMERGENT BIOSOLUT's value examination focuses on studying past and present price action to predict the probability of EMERGENT BIOSOLUT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMERGENT BIOSOLUT's price. Additionally, you may evaluate how the addition of EMERGENT BIOSOLUT to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Money Managers Screen money managers from public funds and ETFs managed around the world |